Literature DB >> 17660128

Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis.

Nagi S El Saghir1, Mazen K Khalil, Toufic Eid, Abdul Rahman El Kinge, Maya Charafeddine, Fady Geara, Muhieddine Seoud, Ali I Shamseddine.   

Abstract

BACKGROUND: Registries and research on breast cancer in Arabic and developing countries are limited.
METHODS: We searched PubMed, Medline, WHO and IAEA publications, national, regional, hospital tumor registries and abstracts. We reviewed and analyzed available data on epidemiological trends and management of breast cancer in Arab countries, and compared it to current international standards of early detection, surgery and radiation therapy.
RESULTS: Breast cancer constitutes 13-35% of all female cancers. Almost half of patients are below 50 and median age is 49-52 years as compared to 63 in industrialized nations. A recent rise of Age-Standardized Incidence Rates (ASR) is noted. Advanced disease remains very common in Egypt, Tunisia, Saudi Arabia, Syria, Palestinians and others. Mastectomy is still performed in more than 80% of women with breast cancer. There are only 84 radiation therapy centers, 256 radiation oncologists and 473 radiation technologists in all Arab countries, as compared with 1875, 3068 and 5155, respectively, in the USA, which has an equivalent population of about 300 million. Population-based screening is rarely practiced. Results from recent campaigns and studies show a positive impact of clinical breast examination leading to more early diagnosis and breast-conserving surgery.
CONCLUSIONS: Breast cancer is the most common cancer among women in Arab countries with a young age of around 50 years at presentation. Locally advanced disease is very common and total mastectomy is the most commonly performed surgery. Awareness campaigns and value of clinical breast examination were validated in the Cairo Breast Cancer Screening Trial. More radiation centers and early detection would optimize care and reduce the currently high rate of total mastectomies. Population-based screening in those countries with affluent resources and accessible care should be implemented.

Entities:  

Mesh:

Year:  2006        PMID: 17660128     DOI: 10.1016/j.ijsu.2006.06.015

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  101 in total

1.  Urban-rural differences in breast cancer incidence in Egypt (1999-2006).

Authors:  Subhojit Dey; Amr S Soliman; Ahmad Hablas; Ibrahim A Seifeldein; Kadry Ismail; Mohamed Ramadan; Hesham El-Hamzawy; Mark L Wilson; Mousumi Banerjee; Paolo Boffetta; Joe Harford; Sofia D Merajver
Journal:  Breast       Date:  2010-05-08       Impact factor: 4.380

Review 2.  Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes.

Authors:  Asma Arabi; Rola El Rassi; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

3.  Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.

Authors:  Young-Hyuck Im; Bulent Karabulut; Keun Seok Lee; Byeong-Woo Park; Aditya Adhav; Havva Yesil Cinkir; Hikmat Abdel-Razeq; Yuan-Ching Chang; Sercan Aksoy; Seock-Ah Im; Joon Jeong; Yeesoo Chae; James Bowles; Khemaies Slimane; Hongling Xue; Sung-Bae Kim
Journal:  Breast Cancer Res Treat       Date:  2021-03-16       Impact factor: 4.872

Review 4.  Burden of surgical disease: does the literature reflect the scope of the international crisis?

Authors:  Breena R Taira; K A Kelly McQueen; Frederick M Burkle
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

5.  Knowledge, attitudes, and beliefs of Arab-American women regarding inherited cancer risk.

Authors:  Suzanne Mellon; Jacqueline Gauthier; Michelle Cichon; Adnan Hammad; Michael S Simon
Journal:  J Genet Couns       Date:  2012-10-10       Impact factor: 2.537

6.  Lay perceptions of breast cancer in Western Kenya.

Authors:  Violet Naanyu; Chite Fredrick Asirwa; Juddy Wachira; Naftali Busakhala; Job Kisuya; Grieven Otieno; Alfred Keter; Anne Mwangi; Orango Elkanah Omenge; Thomas Inui
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 7.  Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.

Authors:  Meteb Al-Foheidi; Mubarak M Al-Mansour; Ezzeldin M Ibrahim
Journal:  Med Oncol       Date:  2013-02-19       Impact factor: 3.064

Review 8.  The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine.

Authors:  Gabriel N Hortobagyi; Nagi S El-Saghir; Tanja Cufer; Eduardo Cazap; Roselle de Guzman; Nicholas Anthony Othieno-Abinya; Jose Angel Sanchez; Doug Pyle
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

9.  Changing trends of breast cancer survival in sultanate of oman.

Authors:  Shiyam Kumar; Ikram A Burney; Adel Al-Ajmi; Mansour S Al-Moundhri
Journal:  J Oncol       Date:  2010-10-25       Impact factor: 4.375

10.  Increased TNF α, IL-6 and ErbB2 mRNA expression in peripheral blood leukocytes from breast cancer patients.

Authors:  Majed S Alokail; Nasser M Al-Daghri; Abdul Khader Mohammed; Paul Vanhoutte; Amal Alenad
Journal:  Med Oncol       Date:  2014-06-25       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.